Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma

AIM: To investigate the factors influenced the efficacy of tolvaptan (TLV) in liver cirrhosis. METHODS: We retrospectively enrolled 61 consecutive patients with refractory hepatic ascites. All of them had been treated with furosemide and spironolactone before admission, and treated with TLV for 7 d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastroenterol
Hlavní autoři: Miyazaki, Masayuki, Yada, Masayoshi, Tanaka, Kosuke, Senjyu, Takeshi, Goya, Takeshi, Motomura, Kenta, Kohjima, Motoyuki, Kato, Masaki, Masumoto, Akihide, Kotoh, Kazuhiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2017
Témata:
Retrospective Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550787/
https://ncbi.nlm.nih.gov/pubmed/28839438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i29.5379
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky